Abstract
Vaccine-associated thrombosis has previously been described in patients presenting with cerebral sinus thrombosis, deep venous thrombosis/pulmonary embolism, or mesenteric venous thrombosis. Only recently has arterial thrombosis gained attention. A new entity known as vaccine-induced thrombotic thrombocytopenia (VITT) has been associated with the coronavirus disease of 2019 (COVID-19) vaccines produced by AstraZeneca and Johnson & Johnson. We describe a case series of three patients who presented with acute limb ischemia with vaccine-associated arterial occlusions, one of whom was diagnosed with VITT.
| Original language | English (US) |
|---|---|
| Article number | 100153 |
| Journal | Annals of Vascular Surgery - Brief Reports and Innovations |
| Volume | 3 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 2023 |
| Externally published | Yes |
Keywords
- Acute limb ischemia (ALI)
- Vaccine-induced thrombotic thrombocytopenia (VITT)
ASJC Scopus subject areas
- Surgery
- Cardiology and Cardiovascular Medicine
Fingerprint
Dive into the research topics of 'Acute limb ischemia secondary to vaccine-induced thrombotic thrombocytopenia'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS